期刊
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 124, 期 -, 页码 181-186出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2022.09.036
关键词
Respiratory tract infection; UTI; Complications; Antibiotic treatment
This study aimed to compare the incidence rate for complications to upper respiratory tract infections (URTIs) and lower urinary tract infections (UTIs) between treated and untreated cases. The results showed that there was no increased risk of complications for untreated URTI cases compared to treated cases. However, for lower UTIs, patients who were not treated with antibiotics had an increased risk of severe infections within 30 days.
Objectives: The objective of this study was to compare the incidence rate for complications to upper respiratory tract infections (URTIs), including acute bronchitis and lower urinary tract infections (UTIs), for those treated with antibiotics compared to those who were not.Methods: This was a population-based retrospective cohort study in Sweden. Patients diagnosed with otitis, pharyngotonsillitis, sinusitis, acute bronchitis, and lower UTI in primary care between 2014 and 2020 were included. Data on prescribed and dispensed antibiotics and comorbidities for each subject were collected. The outcome we investigated was the number of infectious complications within 30 days and if antibiotic treatment had any effect on risk reduction.Results: There were 202,995 episodes of otitis, 388,158 pharyngotonsillitis, 125,792 sinusitis, 220,960 bronchitis, and 377,954 lower UTIs in our cohort. No increased risk for complications was seen for un-treated compared with treated cases with URTI. For lower UTI, the adjusted odds ratio for febrile UTI or bloodstream infection was 1.53 (95% confidence interval 1.39-1.68). Conclusion: The risk for infectious complications from common URTIs is low and not modified by antibi-otic treatment. On the contrary, patients diagnosed with UTI in whom antibiotics were withheld had an increased 30 days risk for severe infections.(c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据